Hands-On therapy tested for lung disease: could osteopathic techniques ease breathing?
NCT ID NCT07548216
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether adding osteopathic manipulative techniques (gentle hands-on bodywork) to standard chest physiotherapy can improve lung function and reduce shortness of breath in people with progressive pulmonary fibrosis. Fifty adults with advanced lung scarring will receive either osteopathic manipulation plus physiotherapy or physiotherapy alone for four weeks. The goal is to see if the combined approach offers extra relief for breathing difficulties.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- osteopathic manipulative techniques
- What this could lead to
- If it works, this could offer a gentle hands-on therapy to help people with progressive pulmonary fibrosis breathe easier and improve their daily comfort.
- What could go wrong
- This is a very small, early-stage study (50 people) testing a complementary therapy, not a cure. The benefits may be modest or not better than standard physiotherapy alone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 50 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
May 2026
An estimate. Start dates often move.
- Expected to finish
-
Oct 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
19 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Their age \> 18. * Both sexes. * Patients without excerbations. * FVC of the patient \<50% . * FEV1/ FVC of the patient \<50%. * Hemodynamic stable. * Conscious and cooperative. * Are able to participate in training actively. Exclusion Criteria: * Patients with acute excerbations. * Acute or Uncontrolled Infections. * Active Malignancy. * Chest deformity
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Osteopathic manipulative treatment are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Hospital of Beni Suef University
Banī Suwayf, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Patients and families build a living database of pulmonary fibrosis
- Can pulmonary fibrosis patients pull hard enough for their inhalers?
- Inhaled therapy aims to slow the march of progressive pulmonary fibrosis
- Beyond the lungs: the hidden emotional toll of IPF medications
- What makes someone stop a lung fibrosis drug? a study asks patients directly
- Which finger or earlobe? a study tests the best spot for oxygen monitoring in lung disease